Treating Breast Cancer with Tunicamycin – A New Paradigm

Breast cancer is a multi-factorial progressive disorder with unknown etiology and exists in multiple molecular subtypes. In the last 50 years, it has become a public health problem diagnosing nearly 2 million cases per year with a mortality rate of approximately half a million, worldwide. Current treatment strategies have not succeeded in eliminating the disease.